{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:26:33Z","timestamp":1790717193433,"version":"4.1.0"},"reference-count":52,"publisher":"Japanese Society of Internal Medicine","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2024,1,1]]},"DOI":"10.2169\/internalmedicine.1551-23","type":"journal-article","created":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T22:11:10Z","timestamp":1678831870000},"page":"1-10","source":"Crossref","is-referenced-by-count":15,"title":["Gastroesophageal Reflux Disease: Pathophysiology and New Treatment Trends"],"prefix":"10.2169","volume":"63","author":[{"given":"Kunio","family":"Kasugai","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Division of Gastroenterology, Aichi Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naotaka","family":"Ogasawara","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Gastroenterology, Aichi Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R; Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 101: 1900-1920; quiz 1943, 2006.","DOI":"10.1111\/j.1572-0241.2006.00630.x"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Smout AJ, Bredenoord AJ. GERD: a challenge to our view of reflux oesophagitis pathogenesis. Nat Rev Gastroenterol Hepatol 13: 504-505, 2016.","DOI":"10.1038\/nrgastro.2016.106"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Tobey NA, Carson JL, Alkiek RA, Orlando RC. Dilated intercellular spaces: a morphological feature of acid reflux - damaged human esophageal epithelium. Gastroenterology 111: 1200-1205, 1996.","DOI":"10.1053\/gast.1996.v111.pm8898633"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Miwa H, Kondo T, Oshima T. Gastroesophageal reflux disease-related and functional heartburn: pathophysiology and treatment. Curr Opin Gastroenterol 32: 344-352, 2016.","DOI":"10.1097\/MOG.0000000000000282"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Souza RF, Huo X, Mittal V, et al. Gastroesophageal reflux might cause esophagitis through a cytokine-mediated mechanism rather than caustic acid injury. Gastroenterology 137: 1776-1784, 2009.","DOI":"10.1053\/j.gastro.2009.07.055"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Dunbar KB, Agoston AT, Odze RD, et al. Association of acute gastroesophageal reflux disease with esophageal histologic changes. JAMA 315: 2104-2112, 2016.","DOI":"10.1001\/jama.2016.5657"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Kondo T, Oshima T, Tomita T, et al. The nonsteroidal anti-inflammatory drug diclofenac reduces acid-induced heartburn symptoms in healthy volunteers. Clin Gastroenterol Hepatol 13: 1249-1255.e1, 2015.","DOI":"10.1016\/j.cgh.2015.01.014"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kahrilas PJ, McColl K, Fox M, et al. The acid pocket: a target for treatment in reflux disease? Am J Gastroenterol 108: 1058-1064, 2013.","DOI":"10.1038\/ajg.2013.132"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Lee RH, Korsapati H, Bhalla V, Varki N, Mittal RK. Esophageal submucosal injection of capsaicin but not acid induces symptoms in normal subjects. J Neurogastroenterol Motil 22: 436-443, 2016.","DOI":"10.5056\/jnm15166"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Bhat YM, Bielefeldt K. Capsaicin receptor (TRPV1) and non-erosive reflux disease. Eur J Gastroenterol Hepatol 18: 263-270, 2006.","DOI":"10.1097\/00042737-200603000-00006"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Kondo T, Sei H, Yamasaki T, et al. A novel prostanoid EP1 receptor antagonist, ONO-8539, reduces acid-induced heartburn symptoms in healthy male volunteers: a randomized clinical trial. J Gastroenterol 52: 1081-1089, 2017.","DOI":"10.1007\/s00535-017-1308-3"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Helm JF, Dodds WJ, Riedel DR, Teeter BC, Hogan WJ, Arndorfer RC. Determinants of esophageal acid clearance in normal subjects. Gastroenterology 85: 607-612, 1983.","DOI":"10.1016\/0016-5085(83)90015-X"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Helm JF, Dodds WJ, Pelc LR, Palmer DW, Hogan WJ, Teeter BC. Effect of esophageal emptying and saliva on clearance of acid from the esophagus. N Engl J Med 310: 284-288, 1984.","DOI":"10.1056\/NEJM198402023100503"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Kahrilas PJ, Dodds WJ, Hogan WJ. Effect of peristaltic dysfunction on esophageal volume clearance. Gastroenterology 94: 73-80, 1988.","DOI":"10.1016\/0016-5085(88)90612-9"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Kahrilas PJ, Bredenoord AJ, Fox M, et al.; International High Resolution Manometry Working Group. The Chicago Classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil 27: 160-174, 2015.","DOI":"10.1111\/nmo.12477"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Helm JF. Role of saliva in esophageal function and disease. Dysphagia 4: 76-84, 1989.","DOI":"10.1007\/BF02407149"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Pandolfino JE, Kahrilas PJ; American Gastroenterological Association. AGA technical review on the clinical use of esophageal manometry. Gastroenterology 128: 209-224, 2005.","DOI":"10.1053\/j.gastro.2004.11.008"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. Mittal RK, Holloway RH, Penagini R, Blackshaw LA, Dent J. Transient lower esophageal sphincter relaxation. Gastroenterology 109: 601-610, 1995.","DOI":"10.1016\/0016-5085(95)90351-8"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Hayashi Y, Iwakiri K, Kotoyori M, Sakamoto C. Mechanisms of acid gastroesophageal reflux in the Japanese population. Dig Dis Sci 53: 1-6, 2008.","DOI":"10.1007\/s10620-007-0038-4"},{"key":"20","unstructured":"20. Evidence-based Clinical Practice Guidelines for Gastroesophageal Reflux Disease (GERD) 2021 (revised 3rd edition). The Japanese Society of Gastroenterology, Ed. Nankodo, Tokyo, 2021."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Tamura Y, Funaki Y, Izawa S, et al. Pathophysiology of functional heartburn based on Rome III criteria in Japanese patients. World J Gastroenterol 21: 5009-5016, 2015.","DOI":"10.3748\/wjg.v21.i16.5009"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Funaki Y, Ogasawara N, Kawamura Y, et al. Effects of acotiamide on functional dyspepsia patients with heartburn who failed proton pump inhibitor treatment in Japanese patients: a randomized, double-blind, placebo-controlled crossover study. Neurogastroenterol Motil 32: e13749, 2020.","DOI":"10.1111\/nmo.13749"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Futagami S, Iwakiri K, Shindo T, et al. The prokinetic effect of mosapride citrate combined with omeprazole therapy improves clinical symptoms and gastric emptying in PPI-resistant NERD patients with delayed gastric emptying. J Gastroenterol 45: 413-421, 2010.","DOI":"10.1007\/s00535-009-0173-0"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Miyamoto M, Manabe N, Haruma K. Efficacy of the addition of prokinetics for proton pump inhibitor (PPI) resistant non-erosive reflux disease (NERD) patients: significance of frequency scale for the symptom of GERD (FSSG) on decision of treatment strategy. Intern Med 49: 1469-1476, 2010.","DOI":"10.2169\/internalmedicine.49.3615"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Tominaga K, Kato M, Takeda H, et al.; G-PRIDE Study Group. A randomized, placebo-controlled, double-blind clinical trial of rikkunshito for patients with non-erosive reflux disease refractory to proton-pump inhibitor: the G-PRIDE study. J Gastroenterol 49: 1392-1405, 2014.","DOI":"10.1007\/s00535-013-0896-9"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Grossi L, Spezzaferro M, Sacco LF, Marzio L. Effect of baclofen on oesophageal motility and transient lower oesophageal sphincter relaxations in GORD patients: a 48-h manometric study. Neurogastroenterol Motil 20: 760-766, 2008.","DOI":"10.1111\/j.1365-2982.2008.01115.x"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Li S, Shi S, Chen F, Lin J. The effects of baclofen for the treatment of gastroesophageal reflux disease: a meta-analysis of randomized controlled trials. Gastroenterol Res Pract 2014: 307805, 2014.","DOI":"10.1155\/2014\/307805"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Falk GW. Inhibition of transient lower esophageal sphincter relaxation in GERD: will lesogaberan advance the field? Gastroenterology 139: 377-379, 2010.","DOI":"10.1053\/j.gastro.2010.06.028"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Broekaert D, Fischler B, Sifrim D, Janssens J, Tack J. Influence of citalopram, a selective serotonin reuptake inhibitor, on oesophageal hypersensitivity: a double-blind, placebo-controlled study. Aliment Pharmacol Ther 23: 365-370, 2006.","DOI":"10.1111\/j.1365-2036.2006.02772.x"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Ostovaneh MR, Saeidi B, Hajifathalian K, et al. Comparing omeprazole with fluoxetine for treatment of patients with heartburn and normal endoscopy who failed once daily proton pump inhibitors: double-blind placebo-controlled trial. Neurogastroenterol Motil 26: 670-678, 2014.","DOI":"10.1111\/nmo.12313"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Kornmo TS, Ruud TE. Long-term results of laparoscopic Nissen fundoplication due to gastroesophageal reflux disease. A ten year follow-up in a low volume center. Scand J Surg 97: 227-230, 2008.","DOI":"10.1177\/145749690809700304"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Broeders JA, Rijnhart-de Jong HG, Draaisma WA, Bredenoord AJ, Smout AJ, Gooszen HG. Ten-year outcome of laparoscopic and conventional Nissen fundoplication: randomized clinical trial. Ann Surg 250: 698-706, 2009.","DOI":"10.1097\/SLA.0b013e3181bcdaa7"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Bona D, Aiolfi A, Asti E, Bonavina L. Laparoscopic Toupet fundoplication for gastroesophageal reflux disease and hiatus hernia: proposal for standardization using the &quot;critical view&quot; concept. Updates Surg 72: 555-558, 2020.","DOI":"10.1007\/s13304-020-00732-7"},{"key":"34","unstructured":"34. Erenoglu C, Miller A, Schirmer B. Laparoscopic Toupet versus Nissen fundoplication for the treatment of gastroesophageal reflux disease. Int Surg 88: 219-225, 2003."},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Peters JH, DeMeester TR. Indications, benefits and outcome of laparoscopic Nissen fundoplication. Dig Dis 14: 169-179, 1996.","DOI":"10.1159\/000171548"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Salminen P, Hiekkanen H, Laine S, Ovaska J. Surgeons&apos; experience with laparoscopic fundoplication after the early personal experience: does it have an impact on the outcome? Surg Endosc 21: 1377-1382, 2007.","DOI":"10.1007\/s00464-006-9156-x"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Brown CN, Smith LT, Watson DI, Devitt PG, Thompson SK, Jamieson GG. Outcomes for trainees vs experienced surgeons undertaking laparoscopic anti-reflux surgery - is equipoise achieved? J Gastrointest Surg 17: 1173-1180, 2013.","DOI":"10.1007\/s11605-013-2211-8"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Garg SK, Gurusamy KS. Laparoscopic fundoplication surgery versus medical management for gastro-oesophageal reflux disease (GORD) in adults. Cochrane Database Syst Rev 2015: CD003243, 2015.","DOI":"10.1002\/14651858.CD003243.pub3"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Sandhu DS, Fass R. Current trends in the management of gastroesophageal reflux disease. Gut Liver 12: 7-16, 2018.","DOI":"10.5009\/gnl16615"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Yadlapati R, Hungness ES, Pandolfino JE. Complications of anti-reflux surgery. Am J Gastroenterol 113: 1137-1147, 2018.","DOI":"10.1038\/s41395-018-0115-7"},{"key":"41","unstructured":"41. Kasugai K, Tokudome K, Funaki Y, Yoneda M. Endoscopic therapy for gastroesophageal reflux disease. Gastroenterol Endosc 51: 1269-1283, 2009 (in Japanese)."},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Tokudome K, Funaki Y, Sasaki M, et al. Efficacy of endoluminal gastroplication in Japanese patients with proton pump inhibitor-resistant, non-erosive esophagitis. World J Gastroenterol 18: 5940-5947, 2012.","DOI":"10.3748\/wjg.v18.i41.5940"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Richter JE, Kumar A, Lipka S, Miladinovic B, Velanovich V. Efficacy of laparoscopic Nissen fundoplication vs. transoral incisionless fundoplication or proton pump inhibitors in patients with gastroesophageal reflux disease: a systematic review and network meta-analysis. Gastroenterology 154: 1298-1308.e7, 2018.","DOI":"10.1053\/j.gastro.2017.12.021"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Zacherl J, Roy-Shapira A, Bonavina L, et al. Endoscopic anterior fundoplication with the Medigus Ultrasonic Surgical Endostapler (MUSE) for gastroesophageal reflux disease: 6-month results from a multi-center prospective trial. Surg Endosc 29: 220-229, 2015.","DOI":"10.1007\/s00464-014-3731-3"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Fass R, Cahn F, Scotti DJ, Gregory DA. Systematic review and meta-analysis of controlled and prospective cohort efficacy studies of endoscopic radiofrequency for treatment of gastroesophageal reflux disease. Surg Endosc 31: 4865-4882, 2017.","DOI":"10.1007\/s00464-017-5431-2"},{"key":"46","unstructured":"46. Inoue H, Ito H, Ikeda H, et al. Anti-reflux mucosectomy for gastroesophageal reflux disease in the absence of hiatus hernia: a pilot study. Ann Gastroenterol 27: 346-351, 2014."},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Sumi K, Inoue H, Kobayashi Y, et al. Endoscopic treatment of proton pump inhibitor-refractory gastroesophageal reflux disease with anti-reflux mucosectomy: experience of 109 cases. Dig Endosc 33: 347-354, 2020.","DOI":"10.1111\/den.13727"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Inoue H, Tanabe M, de Santiago ER, et al. Anti-reflux mucosal ablation (ARMA) as a new treatment for gastroesophageal reflux refractory to proton pump inhibitors: a pilot study. Endosc Int Open 8: E133-E138, 2020.","DOI":"10.1055\/a-1031-9436"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Rodriguez de Santiago E, Sanchez-Vegazo CT, Penas B, et al. Anti-reflux mucosectomy (ARMS) and anti-reflux mucosal ablation (ARMA) for gastroesophageal reflux disease: a systematic review and meta-analysis. Endosc Int Open 9: E1740-E1751, 2021.","DOI":"10.1055\/a-1552-3239"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Ota K, Takeuchi T, Harada S, et al. A novel endoscopic submucosal dissection technique for proton pump inhibitor-refractory gastroesophageal reflux disease. Scand J Gastroenterol 49: 1409-1413, 2014.","DOI":"10.3109\/00365521.2014.978815"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Ota K, Takeuchi T, Kojima Y, et al. Outcomes of endoscopic submucosal dissection for gastroesophageal reflux disease (ESD-G) for medication-refractory gastroesophageal reflux disease: 35 cases underwent ESD-G including 15 cases followed more than 5 years. BMC Gastroenterol 21: 432, 2021.","DOI":"10.1186\/s12876-021-02022-x"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Bytzer P. Goals of therapy and guidelines for treatment success in symptomatic gastroesophageal reflux disease patients. Am J Gastroenterol 98: S31-S39, 2003.","DOI":"10.1016\/S0002-9270(03)00013-3"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/1\/63_1551-23\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T03:31:14Z","timestamp":1704511874000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/1\/63_1551-23\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,1]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.1551-23","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,1]]},"article-number":"1551-23"}}